Ciclopirox Patent Expiration
Ciclopirox is Used for treating interdigital tinea pedis and tinea corporis caused by certain types of fungi. It was first introduced by Medimetriks Pharmaceuticals Inc
Ciclopirox Patents
Given below is the list of patents protecting Ciclopirox, along with the drug name that holds that patent and the company name owning that drug.
Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
---|---|---|---|---|
Ciclopirox | US7018656 | Antimycotic gel with high active substance release |
Sep 05, 2018
(Expired) | Alvogen |
Loprox | US7981909 | Use of 1-hydroxy-2-pyridones for the treatment of seborrheic dermatitis |
Sep 16, 2017
(Expired) | Bausch |
Loprox | US8227490 | Use of 1-hydroxy-2-pyridones for the treatment of seborrheic dermatitis |
Sep 16, 2017
(Expired) | Bausch |
Ciclopirox | US7026337 | Antimycotic gel having high active compound release |
Nov 21, 2016
(Expired) | Alvogen |
A patent's expiry date may change depending upon legal activities going on that patent. Critical
activities like
abandoning of a patent, term extension of a patent or amendment of its claims can increase or
decrease the life of a
patent hence affecting its expiry date and in turn affecting the generic launch date of that
drug. Tracking these
ongoing activities on a patent application helps to keep an eye on the latest developments in
the patent process of
the drug which can give an idea of how early a drug's generic could be available. The next
section provides a list
of recent legal activities on Ciclopirox's patents.
Latest Legal Activities on Ciclopirox's Patents
Given below is the list recent legal activities going on the following patents of Ciclopirox.
Activity | Date | Patent Number |
---|---|---|
![]() | ||
Expire Patent Critical
| 07 May, 2018 | US7026337 |
Maintenance Fee Reminder Mailed Critical
| 20 Nov, 2017 | US7026337 |
Change in Power of Attorney (May Include Associate POA) Critical
| 27 Mar, 2009 | US7026337 |
Correspondence Address Change Critical
| 24 Mar, 2009 | US7026337 |
Change in Power of Attorney (May Include Associate POA) Critical
| 18 Sep, 2007 | US7026337 |
Recordation of Patent Grant Mailed Critical
| 11 Apr, 2006 | US7026337 |
Patent Issue Date Used in PTA Calculation Critical
| 11 Apr, 2006 | US7026337 |
Issue Notification Mailed Critical
| 22 Mar, 2006 | US7026337 |
Dispatch to FDC | 09 Mar, 2006 | US7026337 |
Application Is Considered Ready for Issue Critical
| 27 Jan, 2006 | US7026337 |
Ciclopirox's Family Patents
